DuPont Launches New Chromatography Resins to Accelerate Purification
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 days ago
0mins
Should l Buy DD?
Source: PRnewswire
- Product Launch: DuPont has introduced the DuPont™ AmberChrom™ XT20 SL and XT30 SL chromatography resins, aimed at streamlining downstream purification processes for oligonucleotide and peptide therapeutics, addressing the growing market demand.
- Efficiency Improvement: The new resins eliminate the resin hydration step, allowing manufacturers to move directly from delivery to column packing, significantly reducing preparation time and capital investment, thereby enhancing production efficiency.
- Market Demand: As oligonucleotide and peptide therapies gain traction, manufacturers are under pressure to improve efficiency, and the introduction of these new resins meets this demand while ensuring performance is not compromised.
- Technical Advantages: The XT20 SL resin features a small particle size for high-resolution applications, while the XT30 SL resin optimizes separations at higher flow rates, providing flexibility across various purification steps and strengthening DuPont's competitive position in the bioprocessing sector.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DD
Wall Street analysts forecast DD stock price to rise
10 Analyst Rating
8 Buy
2 Hold
0 Sell
Strong Buy
Current: 46.060
Low
44.00
Averages
49.30
High
59.00
Current: 46.060
Low
44.00
Averages
49.30
High
59.00
About DD
DuPont de Nemours, Inc. is engaged in providing advanced solutions that help transform industries. The Company serves various markets, including healthcare, water, construction, and industrial. It operates through two segments, which include Healthcare & Water Technologies and Diversified Industrials. The Healthcare & Water Technologies segment includes packaging, parts and components for medical device and biopharma markets as well as water filtration and purification technologies primarily for industrial wastewater & energy, municipal drinking water & desalination, and life sciences & specialty markets. The Diversified Industrials segment includes building technologies, with a portfolio serving new-build and repair/remodel applications across non-residential and residential construction markets, and industrial technologies, which includes a portfolio of adhesive, wear and friction, and packaging solutions serving aerospace, automotive and printing and packaging markets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
DuPont to Release Q1 2026 Financial Results on May 5
- Earnings Release Schedule: DuPont is set to announce its Q1 2026 financial results at 6:00 a.m. ET on May 5, 2026, reflecting the company's performance and outlook in key markets.
- Conference Call Details: A conference call will follow at 8:00 a.m. ET, allowing investors to dial in at 888-440-4172 (toll-free in the U.S.) or +1-646-960-0673, with conference ID 5994046, facilitating in-depth analysis of financial conditions.
- Live Webcast Access: The conference call will be webcast live on DuPont's Investor Relations webpage, ensuring global investors can access real-time information, with a replay and earnings materials available post-event to enhance transparency and information accessibility.
- Company Background Information: DuPont is a global innovation leader providing advanced solutions across healthcare, water, construction, and industrial sectors, further solidifying its leadership position in the industry.
See More
DuPont Declares Quarterly Dividend of $0.20 per Share
- Quarterly Dividend Announcement: DuPont's Board of Directors has declared a quarterly dividend of $0.20 per share on its common stock, payable on May 29, 2026, reflecting the company's ongoing cash flow strength and commitment to shareholder returns.
- Record Date for Shareholders: The record date for the dividend payment is set for May 15, 2026, ensuring that shareholders holding stock by this date will receive the dividend, which bolsters investor confidence in the company.
- Company Background: DuPont is recognized as a global innovation leader, providing advanced solutions across key markets such as healthcare, water, construction, and industrial sectors, underscoring its significant role in transforming industries.
- Investor Information Access: Investors can access more information through the Investor Relations section of DuPont's website, enhancing transparency and communication with shareholders, thereby fostering trust in the company's operations.
See More
DUPONT ANNOUNCES QUARTERLY DIVIDEND OF $0.20 PER SHARE FOR COMMON STOCK
- Dividend Announcement: DuPont has declared a quarterly dividend of $0.20 per share on its common stock.
- Shareholder Impact: This dividend payment reflects DuPont's commitment to returning value to its shareholders.
See More
DuPont Launches New Chromatography Resins to Accelerate Purification
- Product Launch: DuPont has introduced the DuPont™ AmberChrom™ XT20 SL and XT30 SL chromatography resins, aimed at streamlining downstream purification processes for oligonucleotide and peptide therapeutics, addressing the growing market demand.
- Efficiency Improvement: The new resins eliminate the resin hydration step, allowing manufacturers to move directly from delivery to column packing, significantly reducing preparation time and capital investment, thereby enhancing production efficiency.
- Market Demand: As oligonucleotide and peptide therapies gain traction, manufacturers are under pressure to improve efficiency, and the introduction of these new resins meets this demand while ensuring performance is not compromised.
- Technical Advantages: The XT20 SL resin features a small particle size for high-resolution applications, while the XT30 SL resin optimizes separations at higher flow rates, providing flexibility across various purification steps and strengthening DuPont's competitive position in the bioprocessing sector.
See More
DuPont Launches New Low Salt Rejection RO Membranes
- Product Launch: DuPont has introduced the FilmTec™ Fortilife™ XC-Max UHP and XC220 reverse osmosis membrane elements aimed at helping industrial customers enhance water recovery and optimize Zero Liquid Discharge (ZLD) and Minimal Liquid Discharge (MLD) system performance to meet increasingly stringent discharge regulations.
- Technical Advantages: The XC220 element can achieve brine concentrations of up to 220 g/L NaCl at operating pressures of 83 bar, enabling users to increase water recovery, reduce downstream treatment steps and liquid waste volumes, thereby lowering overall costs.
- Ultra-High Salinity Applications: The XC-Max UHP element can achieve reject TDS concentrations of 250 g/L NaCl at operating pressures of 120 bar, extending membrane technology into areas traditionally dominated by thermal processes, significantly reducing the water volume required for final thermal treatment steps.
- Sustainability Strategy: DuPont's membrane technologies not only help users comply with evolving regulations but also unlock new pathways toward more sustainable, resilient, and economically attractive MLD/ZLD system designs, supporting efficient management of global water resources.
See More
Meta and Alphabet Face Social Media Lawsuits
- Increased Legal Liability: Meta and Alphabet were ordered to pay $3 million due to mental health issues linked to social media addiction, highlighting the potential impact of social media on user mental health and possibly leading to stricter regulatory policies that could affect their advertising revenue model.
- Investor Sentiment Shift: While shareholders of Meta and Alphabet did not immediately alter their views on the companies, these verdicts may raise concerns about the future of the social media industry, particularly regarding significant reforms that legislation could impose, impacting investor confidence.
- Industry Comparison: The social media sector is being likened to a 'tobacco moment,' where legislative actions could undermine business models; however, historically, tobacco companies have maintained investment returns despite litigation, which may provide a reference point for the future of social media.
- Technological Innovation and Challenges: Meta has become the first customer for ARM's new CPUs, marking a shift in ARM's business model, yet Meta's reliance on multiple suppliers indicates the complexities in technological innovation and market competition.
See More
DuPont to Release Q1 2026 Financial Results on May 5
- Earnings Release Schedule: DuPont is set to announce its Q1 2026 financial results at 6:00 a.m. ET on May 5, 2026, reflecting the company's performance and outlook in key markets.
- Conference Call Details: A conference call will follow at 8:00 a.m. ET, allowing investors to dial in at 888-440-4172 (toll-free in the U.S.) or +1-646-960-0673, with conference ID 5994046, facilitating in-depth analysis of financial conditions.
- Live Webcast Access: The conference call will be webcast live on DuPont's Investor Relations webpage, ensuring global investors can access real-time information, with a replay and earnings materials available post-event to enhance transparency and information accessibility.
- Company Background Information: DuPont is a global innovation leader providing advanced solutions across healthcare, water, construction, and industrial sectors, further solidifying its leadership position in the industry.
See More
DuPont Declares Quarterly Dividend of $0.20 per Share
- Quarterly Dividend Announcement: DuPont's Board of Directors has declared a quarterly dividend of $0.20 per share on its common stock, payable on May 29, 2026, reflecting the company's ongoing cash flow strength and commitment to shareholder returns.
- Record Date for Shareholders: The record date for the dividend payment is set for May 15, 2026, ensuring that shareholders holding stock by this date will receive the dividend, which bolsters investor confidence in the company.
- Company Background: DuPont is recognized as a global innovation leader, providing advanced solutions across key markets such as healthcare, water, construction, and industrial sectors, underscoring its significant role in transforming industries.
- Investor Information Access: Investors can access more information through the Investor Relations section of DuPont's website, enhancing transparency and communication with shareholders, thereby fostering trust in the company's operations.
See More
DUPONT ANNOUNCES QUARTERLY DIVIDEND OF $0.20 PER SHARE FOR COMMON STOCK
- Dividend Announcement: DuPont has declared a quarterly dividend of $0.20 per share on its common stock.
- Shareholder Impact: This dividend payment reflects DuPont's commitment to returning value to its shareholders.
See More
DuPont Launches New Chromatography Resins to Accelerate Purification
- Product Launch: DuPont has introduced the DuPont™ AmberChrom™ XT20 SL and XT30 SL chromatography resins, aimed at streamlining downstream purification processes for oligonucleotide and peptide therapeutics, addressing the growing market demand.
- Efficiency Improvement: The new resins eliminate the resin hydration step, allowing manufacturers to move directly from delivery to column packing, significantly reducing preparation time and capital investment, thereby enhancing production efficiency.
- Market Demand: As oligonucleotide and peptide therapies gain traction, manufacturers are under pressure to improve efficiency, and the introduction of these new resins meets this demand while ensuring performance is not compromised.
- Technical Advantages: The XT20 SL resin features a small particle size for high-resolution applications, while the XT30 SL resin optimizes separations at higher flow rates, providing flexibility across various purification steps and strengthening DuPont's competitive position in the bioprocessing sector.
See More
DuPont Launches New Low Salt Rejection RO Membranes
- Product Launch: DuPont has introduced the FilmTec™ Fortilife™ XC-Max UHP and XC220 reverse osmosis membrane elements aimed at helping industrial customers enhance water recovery and optimize Zero Liquid Discharge (ZLD) and Minimal Liquid Discharge (MLD) system performance to meet increasingly stringent discharge regulations.
- Technical Advantages: The XC220 element can achieve brine concentrations of up to 220 g/L NaCl at operating pressures of 83 bar, enabling users to increase water recovery, reduce downstream treatment steps and liquid waste volumes, thereby lowering overall costs.
- Ultra-High Salinity Applications: The XC-Max UHP element can achieve reject TDS concentrations of 250 g/L NaCl at operating pressures of 120 bar, extending membrane technology into areas traditionally dominated by thermal processes, significantly reducing the water volume required for final thermal treatment steps.
- Sustainability Strategy: DuPont's membrane technologies not only help users comply with evolving regulations but also unlock new pathways toward more sustainable, resilient, and economically attractive MLD/ZLD system designs, supporting efficient management of global water resources.
See More
Meta and Alphabet Face Social Media Lawsuits
- Increased Legal Liability: Meta and Alphabet were ordered to pay $3 million due to mental health issues linked to social media addiction, highlighting the potential impact of social media on user mental health and possibly leading to stricter regulatory policies that could affect their advertising revenue model.
- Investor Sentiment Shift: While shareholders of Meta and Alphabet did not immediately alter their views on the companies, these verdicts may raise concerns about the future of the social media industry, particularly regarding significant reforms that legislation could impose, impacting investor confidence.
- Industry Comparison: The social media sector is being likened to a 'tobacco moment,' where legislative actions could undermine business models; however, historically, tobacco companies have maintained investment returns despite litigation, which may provide a reference point for the future of social media.
- Technological Innovation and Challenges: Meta has become the first customer for ARM's new CPUs, marking a shift in ARM's business model, yet Meta's reliance on multiple suppliers indicates the complexities in technological innovation and market competition.
See More
